Who owns PSYENCE BIOMEDICAL LTD?

Tip: Access positions for across all investors

Analyze quarterly positions in Psyence Biomedical with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Psyence Biomedical stock

Who bought or sold PSYENCE BIOMEDICAL LTD this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Polar Securities 733k $51k 100% Mar 2024
 View chart
MMCAP International Inc. SPC 600k $42k 100% Mar 2024
 View chart
Calamos Advisors 500k $36k 100% Mar 2024
 View chart
Cantor Fitzgerald, L. P. 469k $60k 100% Mar 2024
 View chart
Saba Capital Management 298k $21k 100% Mar 2024
 View chart
Aristeia Capital 273k $20k 100% Mar 2024
 View chart
Context Capital Management 234k $16k 100% Mar 2024
 View chart
LMR Partners 200k $14k 100% Mar 2024
 View chart
Walleye Trading Advisors 198k $14k 100% Mar 2024
 View chart
Clear Street 180k $13k 100% Mar 2024
 View chart
D. E. Shaw & Co 175k $13k 100% Mar 2024
 View chart
Shaolin Capital Management 175k $12k 100% Mar 2024
 View chart
Tenor Capital Management 150k $11M 100% Mar 2024
 View chart
Wolverine Asset Management 135k $9.4k 100% Mar 2024
 View chart
Cowen And Company 130k $9.1k 100% Mar 2024
 View chart
Millennium Management 108k $4.9k 100% Mar 2024
 View chart
Westchester Capital Management 92k $6.6k 100% Mar 2024
 View chart
Mizuho Securities USA 89k $4.5k 100% Mar 2024
 View chart
Yakira Capital Management 77k $5.4k 100% Mar 2024
 View chart
Flow State Investments 55k $3.9k 100% Mar 2024
 View chart
Mint Tower Capital Management B.V. 50k $4.0k 100% Mar 2024
 View chart
Whitebox Advisors 50k $3.5k 100% Mar 2024
 View chart
Walleye Trading 24k $1.7k 100% Mar 2024
 View chart
Schonfeld Strategic Advisors 24k $1.7k 100% Mar 2024
 View chart
SkyView Investment Advisors 18k $999.250000 100% Mar 2024
 View chart
Ancora Advisors 5.0k $350.000000 100% Mar 2024
 View chart
UBS Group 73.00 $5.000500 100% Mar 2024
 View chart